Silence Therapeutics (SLNCF) Change in Account Payables (2020 - 2024)
Historic Change in Account Payables for Silence Therapeutics (SLNCF) over the last 5 years, with Q3 2024 value amounting to -$862735.3.
- Silence Therapeutics' Change in Account Payables fell 82457.14% to -$862735.3 in Q3 2024 from the same period last year, while for Sep 2024 it was $3.2 million, marking a year-over-year increase of 18991.35%. This contributed to the annual value of $54610.7 for FY2023, which is 9695.05% down from last year.
- As of Q3 2024, Silence Therapeutics' Change in Account Payables stood at -$862735.3, which was down 82457.14% from $5.9 million recorded in Q2 2024.
- Silence Therapeutics' 5-year Change in Account Payables high stood at $5.9 million for Q2 2024, and its period low was -$4.2 million during Q1 2022.
- Over the past 5 years, Silence Therapeutics' median Change in Account Payables value was $939551.9 (recorded in 2023), while the average stood at $688904.9.
- The largest annual percentage gain for Silence Therapeutics' Change in Account Payables in the last 5 years was 48142.13% (2024), contrasted with its biggest fall of 82457.14% (2024).
- Silence Therapeutics' Change in Account Payables (Quarter) stood at $2.9 million in 2020, then crashed by 37.27% to $1.8 million in 2021, then plummeted by 247.3% to -$2.7 million in 2022, then skyrocketed by 134.77% to $939551.9 in 2023, then plummeted by 191.82% to -$862735.3 in 2024.
- Its Change in Account Payables was -$862735.3 in Q3 2024, compared to $5.9 million in Q2 2024 and -$2.7 million in Q1 2024.